These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2597177)

  • 1. Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462.
    Schultz E; Nissinen E
    Biochem Pharmacol; 1989 Nov; 38(22):3953-6. PubMed ID: 2597177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.
    Nissinen E; Lindén IB; Schultz E; Kaakkola S; Männistö PT; Pohto P
    Eur J Pharmacol; 1988 Aug; 153(2-3):263-9. PubMed ID: 3181288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT).
    Masjost B; Ballmer P; Borroni E; Zürcher G; Winkler FK; Jakob-Roetne R; Diederich F
    Chemistry; 2000 Mar; 6(6):971-82. PubMed ID: 10785817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor.
    Bonifácio MJ; Vieira-Coelho MA; Soares-da-Silva P
    Eur J Pharmacol; 2003 Jan; 460(2-3):163-70. PubMed ID: 12559377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide.
    Piedrafita FJ; Elorriaga C; Fernández-Alvarez E; Nieto O
    J Enzyme Inhib; 1990; 4(1):43-50. PubMed ID: 2128841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone.
    Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P
    Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone.
    Nissinen E; Lindén IB; Schultz E; Pohto P
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):262-6. PubMed ID: 1407012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat liver catechol-O-methyltransferase by lanthanum. neodymium and europium.
    Quiram DR; Weinshilboum RM
    Biochem Pharmacol; 1976 Aug; 25(15):1727-32. PubMed ID: 942475
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
    Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
    Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase: variation in enzyme activity and inhibition by entacapone and tolcapone.
    De Santi C; Giulianotti PC; Pietrabissa A; Mosca F; Pacifici GM
    Eur J Clin Pharmacol; 1998 May; 54(3):215-9. PubMed ID: 9681662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol O-methyltransferase.
    Borchardt RT
    Methods Enzymol; 1981; 77():267-72. PubMed ID: 7329304
    [No Abstract]   [Full Text] [Related]  

  • 12. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone.
    Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T
    Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of catechol-O-methyl transferase by catechols and polyphenols.
    Baldessarini RJ; Greiner E
    Biochem Pharmacol; 1973 Jan; 22(2):247-56. PubMed ID: 4763253
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of tolcapone upon soluble and membrane-bound brain and liver catechol-O-methyltransferase.
    Vieira-Coelho MA; Soares-da-Silva P
    Brain Res; 1999 Mar; 821(1):69-78. PubMed ID: 10064789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of catechol-O-methyltransferase by 2,3-dihydroxypyridine.
    Raxworthy MJ; Youde IR; Gulliver PA
    Biochem Pharmacol; 1983 Apr; 32(8):1361-4. PubMed ID: 6860355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of catechol O-methyltransferases from brain and liver of rat and human.
    White HL; Wu JC
    Biochem J; 1975 Feb; 145(2):135-43. PubMed ID: 239677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of bridged catechol-homocysteine derivatives as potential inhibitors of catechol O-methyltransferase.
    Lever OW; Hyman C; White HL
    J Pharm Sci; 1984 Sep; 73(9):1241-4. PubMed ID: 6491941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease.
    Lindén IB; Nissinen E; Etemadzadeh E; Kaakkola S; Männistö P; Pohto P
    J Pharmacol Exp Ther; 1988 Oct; 247(1):289-93. PubMed ID: 3171977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.
    Piedrafita FJ; Fernandez-Alvarez E; Nieto O; Tipton KF
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):951-8. PubMed ID: 1417755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.